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Abstract
Introduction Parameters allowing regular evaluation of renal
function in a paediatric intensive care unit (PICU) are not
optimal. The aim of the present study was to analyse the utility of
serum cystatin C and beta2-microglobulin (B2M) in detecting
decreased glomerular filtration rate in critically ill children.
Methods This was a prospective, observational study set in an
eight-bed PICU. Twenty-five children were included. The
inverses of serum creatinine, cystatin C, and B2M were
correlated with creatinine clearance (CrC) using a 24-hour urine
sample and CrC estimation by Schwartz formula (Schwartz).
The diagnostic value of serum creatinine, cystatin C, and B2M
to identify a glomerular filtration rate under 80 ml/minute per
1.73 m2 was evaluated using receiver operating characteristic
(ROC) curve analysis.
Results Mean age was 2.9 years (range, 0.1 to 13.9 years). CrC
was less than 80 ml/minute per 1.73 m2 in 14 children, and
Schwartz was less than 80 ml/minute per 1.73 m2 in 9 children.
Correlations between inverse of B2M and CrC (r = 0.477) and
between inverse of B2M and Schwartz (r = 0.697) were better
than correlations between inverse of cystatin C and CrC (r =
0.390) or Schwartz (r = 0.586) and better than correlations
between inverse of creatinine and CrC (r = 0.104) or Schwartz
(r = 0.442). The ability of serum cystatin C and B2M to identify
a CrC rate and a Schwartz CrC rate under 80 ml/minute per
1.73 m2 was better than that of creatinine (areas under the ROC
curve: 0.851 and 0.792 for cystatin C, 0.802 and 0.799 for
B2M, and 0.633 and 0.625 for creatinine).
Conclusion Serum cystatin C and B2M were confirmed as easy
and useful markers, better than serum creatinine, to detect acute
kidney injury in critically ill children.
Introduction
Glomerular filtration rate (GFR) is difficult to measure in clinical
practice [1-4]. The ideal laboratory marker should be of
endogen synthesis, regular production rate, eliminated only by
glomerular filtration, and without tubular secretion or reabsorp-
tion [4-6]. Creatinine clearance (CrC) using a 24-hour urine
sample and serum creatinine (Cr) are the most commonly
used parameters to estimate GFR in clinical practice
[2,4,5,7,8], although not the most accurate. However, there
are limitations to their use. Cr could be affected by factors
other than renal function (for example, muscle mass, protein
intake, inflammatory illness, or hepatic disease) [2,4,9-12].
Moreover, Cr is partially secreted by renal tubules [2,4,10,13]
and frequently overestimates GFR [1,2,4,5,13]. On the other
hand, CrC requires urine collection over a 24-hour period with
a steady-state situation [1,2,4,11,14]. Mathematical formulas
B2M = beta2-microglobulin; CI = confidence interval; Cr = serum creatinine; CrC = creatinine clearance; GFR = glomerular filtration rate; NS = not 
significant; PICU = paediatric intensive care unit; PRISM = paediatric risk of mortality; ROC = receiver operating characteristic; Schwartz = creatinine 
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using Cr serum levels to estimate GFR (Schwartz formula is
the most widely used and is based on Cr, age, and height)
have been developed [15,16].
To overcome the problems of measuring GFR, an extensive
search is being conducted to find a serum marker able to
detect renal function impairment, especially at the initial phase.
Cystatin C and beta2-microglobulin (B2M) are low-molecular-
weight proteins freely filtered by the glomerulus [1,6,11,12].
Their serum concentrations, especially that of cystatin C, are
less dependent on extra renal factors than in the case of Cr
[1,5,6,10,11,13,14,17,18]. Early detection of renal function
impairment in paediatric intensive care would be of great
value, allowing accurate treatment, adjustment of drug dose,
and prevention of more severe renal damage [3,7,9]. Previous
studies demonstrated the superiority of serum cystatin C com-
pared with creatinine in the evaluation of GFR
[1,5,8,11,13,17-19], especially when there is a minor reduc-
tion in GFR [1,5,6,8,12,13]. We have not found any medical
literature evaluating these low-molecular-weight proteins in
critically ill children. The aim of this study was to evaluate the
accuracies of serum Cr, serum cystatin C, and B2M as mark-
ers of GFR in critically ill children by comparing their results
with CrC and Schwartz.
Materials and methods
Twenty-five children admitted to our paediatric intensive care
unit (PICU) were included in the study. All patients between
the ages of 1 month and 14 years who were admitted due to
an acute illness and who had a bladder catheter were
included. The presence of previous renal or thyroideal pathol-
ogy and the need of renal replacement therapy were consid-
ered exclusion criteria. Demographic and clinical conditions of
the children were recorded. A serum sample was taken regu-
larly from each patient in the morning (between 7 and 8 a.m.)
for creatinine measurement. Cystatin C and B2M were meas-
ured in this sample. A 24-hour urine sample was obtained just
before the serum sample to calculate the CrC adjusted to
adult body surface area by means of the following formula:
CrC (in millilitres/minute per 1.73 m2) = [(urine volume × urine
Cr)/(serum Cr × 1,440)] × (1.73 m2/body surface). Schwartz
CrC rate was calculated using the following formula: (height ×
k)/Cr, where height is calculated in centimetres, k = 0.44 for
children under two years old and 0.55 for children over two
years, and Cr is serum creatinine. Blood and urine samples
were obtained 2.8 days (range, 1 to 6 days) after admission to
the PICU. Serum and urine creatinine levels were measured
using standard laboratory methods. Renal dysfunction was
defined as CrC or as CrC estimation by Schwartz less than 80
ml/minute per 1.73 m2. Serum cystatin C and B2M levels were
determined by endpoint nephelometry in a BN-II device (Dade
Behring Marburg GmbH, Marburg, Germany).
Statistical analysis was performed using SPSS 11.0 (SPSS
Inc., Chicago, IL, USA) and EPIDAT 3.0 (Xunta de Galicia,
Galicia, Spain, and World Health Organization, 2003) for Win-
dows. Data are expressed as a mean value and 95% confi-
dence interval (CI) unless indicated otherwise. Inverses of Cr,
cystatin C, and B2M were correlated with CrC and with
Schwartz. We used the inverses of creatinine, cystatin C, and
B2M to obtain a direct correlation with CrC and Schwartz for-
mula. Correlations between age and CrC, Schwartz, creati-
nine, cystatin C, and B2M were performed. The diagnostic
value of Cr, cystatin C, and B2M for identifying CrC or
Schwartz less than 80 ml/minute per 1.73 m2 was evaluated
using receiver operating characteristic (ROC) curve analysis.
Sensitivity, specificity, and positive likelihood ratio were calcu-
lated. A p value of less than 0.05 was considered statistically
significant. Each patient's determinations were made with the
informed consent of their parents.
Results
The mean age was 2.9 years (95% CI, 1.4 to 4.3 years) with a
range of 0.1 to 13.9 years and a median of 1.3 years. Male/
female ratio was 1.27:1. Mean height was 86.3 cm (range,
53.0 to 151.0 cm). Mean body surface area was 0.5 m2
(range, 0.2 to 1.5 m2). Mean paediatric risk of mortality
(PRISM) [20] (standard deviation [SD]) scores 24 hours after
admission were 15.0 (11.3). The patients' clinical conditions
and the treatments they received are summarized in Table 1.
The mean CrC was 76.3 ml/minute per 1.73 m2 (95% CI, 58.4
to 94.1 ml/minute per 1.73 m2) and the mean Schwartz was
104.5 ml/minute per 1.73 m2 (95% CI, 88.3 to 120.8 ml/
minute per 1.73 m2). The mean serum Cr concentration was
0.42 mg/dl (95% CI, 0.36 to 0.48 mg/dl), the mean serum
cystatin C concentration was 0.69 mg/l (95% CI, 0.57 to 0.81
mg/l), and the mean serum B2M concentration was 2.12 mg/
l (95% CI, 1.66 to 2.57 mg/l). There were no significant differ-
ences between male and female regarding CrC (79.9 versus
71.7 ml/minute per 1.73 m2), Schwartz (103.7 versus 105.5
ml/minute per 1.73 m2), serum Cr (0.43 versus 0.42 mg/dl),
serum cystatin C (0.65 versus 0.75 mg/l), and serum B2M
(2.23 versus 1.97 mg/l).
Fourteen out of the 25 patients enrolled in the study (56.0%)
had a CrC less than 80 ml/minute per 1.73 m2, and 9 patients
(36%) had a Schwartz less than 80 ml/minute per 1.73 m2.
CrC, Schwartz, serum Cr, serum cystatin C, and serum B2M
values are listed in Table 2, separating patients in two groups:
renal dysfunction (CrC less than 80 ml/minute per 1.73 m2)
and normal renal function. Schwartz, CrC, serum Cr, serum
cystatin C, and serum B2M are listed in Table 3, separating
patients in two groups: renal dysfunction (Schwartz less than
80 ml/minute per 1.73 m2) and normal renal function.
Mean PRISM (SD) scores were 13.5 (14.5) in the group with
CrC less than 80 ml/minute per 1.73 m2 and 10.2 (5.1) in the
group with CrC greater than 80 ml/minute per 1.73 m2 (differ-
ences not significant [NS]). Mean PRISM (SD) scores wereAvailable online http://ccforum.com/content/11/3/R59
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15.9 (16.5) in the group with Schwartz less than 80 ml/minute
per 1.73 m2 and 9.6 (5.7) in the group with Schwartz greater
than 80 ml/minute per 1.73 m2 (differences NS).
The correlation with CrC was better for the inverse of serum
B2M (r = 0.477, p < 0.05) than for the inverse of cystatin C (r
= 0.390, p = 0.054). The inverse of Cr showed the worse cor-
relation with CrC (r = 0.104, differences NS). The correlation
with Schwartz was also better for the inverse of serum B2M (r
= 0.697, p < 0.01) than for the inverse of cystatin C (r =
0.586, p < 0.01). The inverse of Cr showed the worse corre-
lation with Schwartz (r = 0.442, p < 0.05).
Patient age in the renal dysfunction group was significantly
lower than in the normal renal function group, 1.6 years (95%
CI, 0.3 to 2.8 years) versus 4.7 years (95% CI, 1.8 to 7.5
years) if GFR was estimated with CrC and 0.9 years (95% CI,
0.3 to 1.5 years) versus 4.1 years (95% CI, 1.9 to 6.2 years) if
GFR was estimated with Schwartz. Age had a lineal correla-
tion with CrC (r = 0.42, p < 0.05), Schwartz (r = 0.41, p <
0.05), and Cr (r = 0.54, p < 0.01), but not with cystatin C (r =
0.10, differences NS) and B2M (r = 0.23, differences NS).
ROC curves for detecting renal dysfunction are shown in Fig-
ures 1 and 2. To diagnose CrC less than 80 ml/minute per
1.73 m2, the areas under the curve were 0.633 (95% CI,
0.403 to 0.863) for serum Cr, 0.851 (95% CI, 0.698 to 1.003)
for serum cystatin C, and 0.802 (95% CI, 0.628 to 0.976) for
serum B2M. To diagnose Schwartz less than 80 ml/minute per
1.73 m2, the areas under the curve were 0.625 (95% CI,
Table 1
Clinical conditions and treatments patients received during urine collection
Parameter Number (percentage) of patients
Disease
Infectious disease 7 (28)
Multiple trauma 4 (16)
Respiratory disease 4 (16)
Metabolic disease 4 (16)
Postsurgical high risk 3 (12)
Neurological disease 3 (12)
Treatment
Mechanical ventilation 13 (52)
Inotropic drugs 12 (48)
Diuretics (bolus) 9 (36)
Diuretics (continuous perfusion) 3 (12)
Enteral nutrition 14 (56)
Table 2
Comparison of groups with creatinine clearance lower and higher than 80 ml/minute per 1.73 m2
CrC < 80 ml/minute per 1.73 m2 CrC > 80 ml/minute per 1.73 m2 P value
N Mean (95% CI) N Mean (95% CI)
CrC 14 47.7 (40.6–54.8) 11 112.6 (85.0–140.3) < 0.01
Schwartz 14 82.8 (64.6–100.9) 11 132.2 (111.7–152.7) < 0.01
Serum Cr (mg/dl) 14 0.45 (0.36–0.54) 11 0.38 (0.29–0.47) NS
Serum cystatin C (mg/l) 14 0.83 (0.67–0.99) 11 0.51 (0.38–0.64) < 0.01
Serum B2M (mg/l) 14 2.60 (1.94–3.26) 11 1.50 (1.02–1.90) < 0.05
Creatinine clearance (CrC), creatinine clearance estimation by Schwartz formula (Schwartz), serum creatinine (Cr), serum cystatin C, and serum 
beta2-microglobulin (B2M) in patients with renal dysfunction (CrC less than 80 ml/minute per 1.73 m2) and normal renal function are shown. CI, 
confidence interval; N, number of patients; NS, not significant.Critical Care    Vol 11 No 3    Herrero-Morín et al.
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0.403 to 0.847) for serum Cr, 0.792 (95% CI, 0.598 to 0.986)
for serum cystatin C, and 0.799 (95% CI, 0.622 to 0.976) for
serum B2M.
The diagnosis efficacy of each marker we studied to detect
renal dysfunction is shown in Tables 4 and 5. For each varia-
ble, the cutoff level with best sensitivity and specificity was
chosen.
Discussion
Gold standard techniques to assess GFR are based on exog-
enous substance clearance (inulin, iodine 125-iothalamate,
technetium 99m-DTPA [diethylenetriaminepentaacetic acid],
chromium 51-EDTA [ethylenediaminetetraacetic acid], ...) [1-
4,21]. However, these methods are difficult to apply in clinical
practice [1,3,7,10,13,14,21,22]. We chose CrC and
Schwartz formula as gold standards because they are com-
monly used in clinical practice. Because urine collection tech-
nique during 24 hours is a limiting factor in children, we
included only those children who had a bladder catheter in
place. Serum Cr level is frequently used in daily practice
[2,4,5,7,8]. However, only two criteria of an ideal GFR marker
are accomplished by serum Cr: endogenous substance and
free glomerular filtration [11]. Serum Cr level is affected by cir-
cumstances other than renal ones [2,4,9-12,21] and it is
secreted by the renal tubules [2,4,10,13]. This leads to an
overestimation of GFR, especially when a moderate GFR
descent is present [1,2,4,5,13,21]. Serum Cr could not detect
renal failure until GFR decreases more than 50% [10,12]. Our
results showed that serum Cr levels were not statistically dif-
ferent in the groups with a level higher or lower than 80 ml/
minute per 1.73 m2, confirming the low sensitivity of serum Cr
to detect renal dysfunction. In critically ill children, there would
be a muscle loss and a relative malnutrition; in these cases,
serum Cr could also indicate GFR values higher than the
actual levels [2,10,12,23].
Cystatin C and B2M are low-molecular-weight proteins pro-
duced by all nucleated cells at a constant rate [1,2,4-6,8,9,11-
14,18,24]. They are freely filtered by the glomerulus and reab-
sorbed and catabolized by proximal tubular cells [2,4-
6,8,9,11-14,18,23,24]. Therefore, their serum values could be
a better marker of GFR than serum Cr level [1,6,24].
The molecular weight of cystatin C is 13.3 kDa
[1,2,4,5,8,9,11,14,18,22,24].  Its concentration is more
dependent on renal function in comparison with serum Cr
[1,14,21,23]. However, some authors found that serum cysta-
tin C concentration could increase in hyperthyroidism or in
patients who are receiving corticosteroids [3,8,11,18,21,23],
although other studies did not find this association [1,15,25].
The molecular weight of B2M is 11.8 kDa [6,22]. It is not influ-
enced by age [5,17], gender, or muscle mass [12,19]. How-
ever, unlike production of cystatin C, that of B2M increases in
infectious or inflammatory process, proliferative syndromes,
and hepatic and autoimmune illnesses [1,5,6,12,26].
Several studies have demonstrated the capacity of cystatin C
to estimate GFR [8,9,11,13,14,18,19,24] and that its ability to
detect moderate acute kidney injury was better than that of Cr
[1,5,6,8,13,19,23,24]. Cystatin C values will be abnormally
high when GFR decreases to 88 to 95 ml/minute per 1.73 m2
[6,13,19]. Therefore, cystatin C could detect renal dysfunction
one to two days before Cr [8]. Cystatin C was also superior to
Cr in children and patients with muscle loss [5,14,18]. Recent
studies have developed formulas that include cystatin C
[15,16]. Some of them also include serum Cr and other fac-
tors like age, weight, and height, improving diagnostic
accuracy. Other authors have shown that parameters such as
urinary neutrophil gelatinase-associated lipocalin and inter-
leukin-18 were superior to serum Cr for acute kidney injury
diagnosis [27-29]. However, new evaluations will be needed.
B2M also increases before Cr [12,19]. Some studies found
Table 3
Comparison of groups with creatinine clearance estimation by Schwartz formula lower and higher than 80 ml/minute per 1.73 m2
Schwartz < 80 ml/minute per 1.73 m2 Schwartz > 80 ml/minute per 1.73 m2 P value
N Mean (95% CI) N Mean (95% CI)
Schwartz 9 68.8 (63.2–74.3) 16 124.6 (105.8–143.5) < 0.01
CrC 9 54.5 (48.4–60.6) 16 88.5 (61.8–115.2) < 0.05
Serum Cr (mg/dl) 9 0.45 (0.35–0.56) 16 0.41 (0.32–0.49) NS
Serum cystatin C 
(mg/l)
9 0.82 (0.67–0.97) 16 0.62 (0.45–0.79) NS
Serum B2M (mg/l) 9 2.73 (1.94–3.52) 16 1.77 (1.23–2.33) < 0.05
Creatinine clearance estimation by Schwartz formula (Schwartz), creatinine clearance (CrC), serum creatinine (Cr), serum cystatin C, and serum 
beta2-microglobulin (B2M) in patients with renal dysfunction (Schwartz less than 80 ml/minute per 1.73 m2) and normal renal function are shown. 
CI, confidence interval; N, number of patients; NS, not significant.Available online http://ccforum.com/content/11/3/R59
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B2M to be less adequate than cystatin C as a GFR marker
[18,24,26], but one other did not show any differences [6].
It has been demonstrated that low-molecular-weight proteins
have greater diagnostic sensitivity than serum Cr in children
[17,25] and critically ill adults [7,9,23]. However, to date, no
studies have been performed in critically ill children.
We found CrC less than 80 ml/minute per 1.73 m2 in 56% and
Schwartz less than 80 ml/minute per 1.73 m2 in 37.5% of the
cases, similar to other studies with critically ill patients [7,9].
Patients with CrC less than 80 ml/minute per 1.73 m2 and with
Schwartz less than 80 ml/minute per 1.73 m2 were younger
than patients with normal renal function. Like previous studies
[1,12,17-19,25], we did not find gender differences in cystatin
C and B2M levels.
As shown in Figures 1 and 2, we found that the capacities of
cystatin C and B2M to detect acute kidney injury were better
than that of serum Cr. Filler and colleagues [17] obtained sim-
ilar results to detect patients with GFR less than 90 ml/minute
per 1.73 m2 in 225 children with different chronic renal dis-
eases; the areas under the ROC curve were 0.840, 0.943,
and 0.899 for serum Cr, cystatin C, and B2M, respectively.
Our study showed worse figures for serum Cr, with areas
under the ROC curve of 0.633 and 0.625. The probable expla-
nation is that our patients were critically ill. In these patients,
serum Cr demonstrated an insufficient sensibility to detect
early acute kidney injury. Hoste and colleagues [7] and
Delanaye and colleagues [23] found normal levels of serum Cr
in critically ill adults when 46.4% and 42% of them, respec-
tively, had CrC less than 80 ml/minute per 1.73 m2. Villa and
colleagues [9] and Delanaye and colleagues [23] found a bet-
ter correlation of CrC with the inverse of cystatin C than with
the inverse of Cr (r = 0.832 versus 0.426 and r = 0.68 versus
0.4, respectively). They also found a higher cystatin C
sensitivity to detect CrC less than 80 ml/minute per 1.73 m2
(areas under the ROC curve, 0.927 versus 0.694 and 0.833
versus 0.789, respectively). Le Bricon and colleagues [14]
found the same results in critically ill adults.
Figure 1
Receiver operating characteristic curves to diagnose creatinine clear- ance of less than 80 ml/minute per 1.73 m2 Receiver operating characteristic curves to diagnose creatinine clear-
ance of less than 80 ml/minute per 1.73 m2. Areas under the curve 
(95% confidence intervals) are 0.633 (0.403 to 0.863) for creatinine, 
0.851 (0.698 to 1.003) for cystatin C, and 0.802 (0.628 to 0.976) for 
beta2-microglobulin (B2M).
Figure 2
Receiver operating characteristic curves to diagnose creatinine clear- ance estimation by Schwartz formula of less than 80 ml/minute per  1.73 m2 Receiver operating characteristic curves to diagnose creatinine clear-
ance estimation by Schwartz formula of less than 80 ml/minute per 
1.73 m2. Areas under the curve (95% confidence intervals) are 0.625 
(0.403 to 0.847) for creatinine, 0.792 (0.598 to 0.986) for cystatin C, 
and 0.799 (0.622 to 0.976) for beta2-microglobulin (B2M).
Table 4
Diagnostic efficiency values for serum creatinine, cystatin C, and beta2-microglobulin to detect early renal dysfunction
Serum creatinine Cystatin C Beta2-microglobulin
Cutoff value 0.4 mg/dl 0.6 mg/l 1.5 mg/l
Sensitivity 42% (39%–46%) 85% (82%–89%) 85% (82%–89%)
Specificity 54% (49%–59%) 63% (58%–68%) 54% (49%–59%)
Positive likelihood ratio 0.94 (0.94–0.95) 2.3 (2.3–2.3) 1.8 (1.8–1.8)
Sensitivity, specificity, and positive likelihood ratio (95% confidence interval) for serum creatinine, cystatin C, and beta2-microglobulin to diagnose 
renal dysfunction (creatinine clearance less than 80 ml/minute per 1.73 m2) are shown.Critical Care    Vol 11 No 3    Herrero-Morín et al.
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In critically ill children, early diagnosis of renal impairment is
very important for making therapeutic decisions [3,7,9]. There-
fore, we tried to determine the best marker to detect CrC and
Schwartz less than 80 ml/minute 1.73 m2. Cystatin C and
B2M had a better area under the ROC curve than Cr. Cystatin
C and B2M had better diagnostic efficiency values than Cr
(Tables 4 and 5). As previously shown in other groups of
patients [5], in our experience serum cystatin C and B2M are
better markers than serum Cr to detect acute kidney injury in
critically ill children. One possible explanation is that GFR in
critically ill children can change rapidly, but changes in serum
Cr take more time.
We obtained cutoff values to differentiate patients with CrC
and with Schwartz less than 80 ml/minute 1.73 m2 that were
considered normal in previous studies [5,11,17,18,30]. A pos-
sible explanation was the early determination of the biological
markers at the beginning of renal dysfunction. Longitudinal
assessment of GFR markers over a period of time will be use-
ful to determine their value for the early diagnosis of GFR
decrease.
Patients with CrC and Schwartz less than 80 ml/minute 1.73
m2 were younger. Age correlates with Cr but not with cystatin
C and B2M. Therefore, age did not influence the higher cysta-
tin C concentration found in patients with low CrC or low
Schwartz.
Our study has limitations. The main problem is the 'gold stand-
ard' against which low-molecular-weight proteins can be cali-
brated. CrC using a 24-hour urine sample and Schwartz
formula based on serum Cr and height were considered the
gold standard because, despite the controversy, they are used
in clinical practice. Another limitation of our study was the size
of the sample and the difference in the ages of the patients.
Because of the small size of the sample, we cannot compare
children older than one year and those younger than one year.
Conclusion
In our experience, serum cystatin C and B2M were confirmed
as simple and useful markers, better than serum Cr, to detect
acute kidney injury in critically ill children. However, new stud-
ies with a bigger sample of patients and more accurate gold
standards to use for comparisons will be necessary to estab-
lish cystatin C or B2M as biochemical markers for monitoring
GFR in unstable critically ill children.
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